Stock Comparison
BNTX vs REGN
BioNTech SE and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$23.36B
$80.55B
P/E (TTM)
—
19.4
Forward P/E
7.0
17.1
Price/Sales
8.8
5.2
Price/Book
1.1
2.5
EV/EBITDA
32.5
13.1
Dividend Yield
—
0.45%
Profitability
Net Margin
-44.95%
29.65%
Operating Margin
-51.83%
24.32%
Return on Equity
-9.30%
14.00%
Return on Assets
-5.41%
6.53%
Growth (YoY)
Revenue Growth
-59.50%
16.70%
Earnings Growth
-43.20%
-4.50%
Price & Risk
Beta
1.3
0.2
52-Week High
$119.34
$810.12
52-Week Low
$83.89
$553.38
Analyst Target
$120.75
$833.54
Compare BNTX and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.